Literature DB >> 16251211

Homeotic factor ATBF1 induces the cell cycle arrest associated with neuronal differentiation.

Cha-Gyun Jung1, Hye-Jung Kim, Makoto Kawaguchi, Kum Kum Khanna, Hideki Hida, Kiyofumi Asai, Hitoo Nishino, Yutaka Miura.   

Abstract

The present study aimed to elucidate the function of AT motif-binding factor 1 (ATBF1) during neurogenesis in the developing brain and in primary cultures of neuroepithelial cells and cell lines (Neuro 2A and P19 cells). Here, we show that ATBF1 is expressed in the differentiating field in association with the neuronal differentiation markers beta-tubulin and MAP2 in the day E14.5 embryo rat brain, suggesting that it promotes neuronal differentiation. In support of this, we show that ATBF1 suppresses nestin expression, a neural stem cell marker, and activates the promoter of Neurod1 gene, a marker for neuronal differentiation. Furthermore, we show that in Neuro 2A cells, overexpressed ATBF1 localizes predominantly in the nucleus and causes cell cycle arrest. In P19 cells, which formed embryonic bodies in the floating condition, ATBF1 is mainly cytoplasmic and has no effect on the cell cycle. However, the cell cycle was arrested when ATBF1 became nuclear after transfer of P19 cells onto adhesive surfaces or in isolated single cells. The nuclear localization of ATBF1 was suppressed by treatment with caffeine, an inhibitor of PI(3)K-related kinase activity of ataxa-telangiectasia mutated (ATM) gene product. The cytoplasmic localization of ATBF1 in floating/nonadherent cells is due to CRM1-dependent nuclear export of ATBF1. Moreover, in the embryonic brain ATBF1 was expressed in the cytoplasm of proliferating stem cells on the ventricular zone, where cells are present at high density and interact through cell-to-cell contact. Conversely, in the differentiating field, where cell density is low and extracellular matrix is dense, the cell-to-matrix interaction triggered nuclear localization of ATBF1, resulting in the cell cycle arrest. We propose that ATBF1 plays an important role in the nucleus by organizing the neuronal differentiation associated with the cell cycle arrest.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16251211     DOI: 10.1242/dev.02098

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  35 in total

1.  Heterozygous deletion of Atbf1 by the Cre-loxP system in mice causes preweaning mortality.

Authors:  Xiaodong Sun; Xiaoying Fu; Jie Li; Changsheng Xing; David W Martin; Helen Heju Zhang; Zhengjia Chen; Jin-Tang Dong
Journal:  Genesis       Date:  2012-06-21       Impact factor: 2.487

2.  Atbf1 is required for the Pit1 gene early activation.

Authors:  Yingchuan Qi; Jeffrey A Ranish; Xiaoyan Zhu; Anna Krones; Jie Zhang; Ruedi Aebersold; David W Rose; Michael G Rosenfeld; Catherine Carrière
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-13       Impact factor: 11.205

Review 3.  Emerging directions in the genetics of atrial fibrillation.

Authors:  Nathan R Tucker; Patrick T Ellinor
Journal:  Circ Res       Date:  2014-04-25       Impact factor: 17.367

4.  ZFHX3 mutation as a protective biomarker for immune checkpoint blockade in non-small cell lung cancer.

Authors:  Jiexia Zhang; Ningning Zhou; Anqi Lin; Xin Chen; Peng Luo; Huojin Deng; Shijun Kang; Linlang Guo; Weiliang Zhu; Jian Zhang
Journal:  Cancer Immunol Immunother       Date:  2020-07-11       Impact factor: 6.968

5.  Proteomic analysis of Sox2-associated proteins during early stages of mouse embryonic stem cell differentiation identifies Sox21 as a novel regulator of stem cell fate.

Authors:  Sunil K Mallanna; Briana D Ormsbee; Michelina Iacovino; Joshua M Gilmore; Jesse L Cox; Michael Kyba; Michael P Washburn; Angie Rizzino
Journal:  Stem Cells       Date:  2010-10       Impact factor: 6.277

Review 6.  New advances in the genetic basis of atrial fibrillation.

Authors:  Saagar Mahida; Patrick T Ellinor
Journal:  J Cardiovasc Electrophysiol       Date:  2012-10-15

7.  Variants in ZFHX3 are associated with atrial fibrillation in individuals of European ancestry.

Authors:  Emelia J Benjamin; Kenneth M Rice; Dan E Arking; Arne Pfeufer; Charlotte van Noord; Albert V Smith; Renate B Schnabel; Joshua C Bis; Eric Boerwinkle; Moritz F Sinner; Abbas Dehghan; Steven A Lubitz; Ralph B D'Agostino; Thomas Lumley; Georg B Ehret; Jan Heeringa; Thor Aspelund; Christopher Newton-Cheh; Martin G Larson; Kristin D Marciante; Elsayed Z Soliman; Fernando Rivadeneira; Thomas J Wang; Gudny Eiríksdottir; Daniel Levy; Bruce M Psaty; Man Li; Alanna M Chamberlain; Albert Hofman; Ramachandran S Vasan; Tamara B Harris; Jerome I Rotter; W H Linda Kao; Sunil K Agarwal; Bruno H Ch Stricker; Ke Wang; Lenore J Launer; Nicholas L Smith; Aravinda Chakravarti; André G Uitterlinden; Philip A Wolf; Nona Sotoodehnia; Anna Köttgen; Cornelia M van Duijn; Thomas Meitinger; Martina Mueller; Siegfried Perz; Gerhard Steinbeck; H-Erich Wichmann; Kathryn L Lunetta; Susan R Heckbert; Vilmundur Gudnason; Alvaro Alonso; Stefan Kääb; Patrick T Ellinor; Jacqueline C M Witteman
Journal:  Nat Genet       Date:  2009-07-13       Impact factor: 38.330

8.  A survey of well conserved families of C2H2 zinc-finger genes in Daphnia.

Authors:  Arun Seetharam; Yang Bai; Gary W Stuart
Journal:  BMC Genomics       Date:  2010-04-30       Impact factor: 3.969

9.  Zinc Finger Homeodomain Factor Zfhx3 Is Essential for Mammary Lactogenic Differentiation by Maintaining Prolactin Signaling Activity.

Authors:  Dan Zhao; Gui Ma; Xiaolin Zhang; Yuan He; Mei Li; Xueying Han; Liya Fu; Xue-Yuan Dong; Tamas Nagy; Qiang Zhao; Li Fu; Jin-Tang Dong
Journal:  J Biol Chem       Date:  2016-04-20       Impact factor: 5.157

10.  Identification of Drosophila Zfh2 as a Mediator of Hypercapnic Immune Regulation by a Genome-Wide RNA Interference Screen.

Authors:  Iiro Taneli Helenius; Ryan J Haake; Yong-Jae Kwon; Jennifer A Hu; Thomas Krupinski; S Marina Casalino-Matsuda; Peter H S Sporn; Jacob I Sznajder; Greg J Beitel
Journal:  J Immunol       Date:  2015-12-07       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.